UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma
Ubiquitin-conjugating enzyme 2C (UBE2C) involves in numerous cellular processes and the tumor progression in many cancers. However, its role in oral squamous cell carcinoma (OSCC) is unclear. We aimed to investigate the role and clinical significance of UBE2C in OSCC. The expression levels of UBE2C...
Main Authors: | Pei-Feng Liu, Chun-Feng Chen, Chih-Wen Shu, Hui-Min Chang, Cheng-Hsin Lee, Huei-Han Liou, Luo-Ping Ger, Chun-Lin Chen, Bor-Hwang Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/9/674 |
Similar Items
-
Squamous Cell Carcinoma of the Tongue Remaining Indolent for 8-Years
by: Bipin Thomas Varghese, et al.
Published: (2020-01-01) -
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
by: Li Hu, et al.
Published: (2021-05-01) -
Effects of UBE2N Knockdown on Radiosensitivity of Human Laryngeal Squamous Cell Carcinoma hep-2 Cells
by: GONG Mengxiao, et al.
Published: (2019-07-01) -
High immune cytolytic activity in tumor‐free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue
by: Xiaolian Gu, et al.
Published: (2019-10-01) -
UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
by: Hao Yang, et al.
Published: (2020-06-01)